Rivanna has secured clearance from the U.S. Food and Drug Administration (FDA) for its Accuro 3S diagnostic ultrasound system and integrated SpineNav-AI image processing software.
Accuro 3S is a portable, point-of-care ultrasound system with a proprietary dual-array convex probe. The probe consists of two aligned transducer arrays arranged side by side with a narrow gap, which enables an in-line needle approach through the probe's center, the company said. Images from both arrays are combined to optimize anatomical visualization.
The integrated SpineNav-AI software is designed for musculoskeletal imaging assessments of the lumbar spine and supports real-time visualization during anesthesia procedures. It provides automated landmark detection and identification of critical spinal anatomy, which may assist clinicians by standardizing interpretation of spinal images, Rivanna said.
